Journal of Drug Targeting

Papers
(The TQCC of Journal of Drug Targeting is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A comprehensive review on the antiviral activities of chalcones76
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects62
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease44
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances39
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status38
Targetting ferroptosis for blood cell-related diseases38
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics36
ABC transporters in breast cancer: their roles in multidrug resistance and beyond35
Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications33
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway32
The relevant targets of anti-oxidative stress: a review31
A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application31
Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats29
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide29
Niosomal formulation for antibacterial applications28
An updated review on exosomes: biosynthesis to clinical applications27
Mitochondria autophagy: a potential target for cancer therapy27
Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis26
Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation26
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease25
Potential inhibitors of SARS-CoV-2: recent advances25
Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells21
Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway21
PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery21
MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson’s disease21
EGFR and anti-EGFR nanobodies: review and update20
A mechanistic perspective on targeting bacterial drug resistance with nanoparticles20
Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer19
Methods for fabricating oxygen releasing biomaterials19
The role of peptide-based therapeutics in oncotherapy19
Nanoliposomes as drug delivery systems: safety concerns19
Micro and nanorobot-based drug delivery: an overview18
Immunotoxins and nanobody-based immunotoxins: review and update18
HSP60 in cancer: a promising biomarker for diagnosis and a potentially useful target for treatment18
Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer’s disease in rats via the Rho/ROCK signalling pathway17
Mesencephalic astrocyte-derived neurotrophic factor restores blood–brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway17
Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer17
Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver17
Progress in tumour-targeted drug delivery based on cell-penetrating peptides16
Functionality of receptor targeted zinc-insulin quantum clusters in skin tissue augmentation and bioimaging16
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance16
Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease16
Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth15
ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints15
Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases15
Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism15
Targeting PRAS40: a novel therapeutic strategy for human diseases15
Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme15
New generation of viral nanoparticles for targeted drug delivery in cancer therapy15
Mycobacterial ethambutol responsive genes and implications in antibiotics resistance14
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection14
Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art14
Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment14
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide14
TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy14
Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)14
Light mediated drug delivery systems: a review14
Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases14
Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy13
A pH-Driven indomethacin-loaded nanomedicine for effective rheumatoid arthritis therapy by combining with photothermal therapy13
Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review13
Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis13
Sirtuins as therapeutic targets for improving delayed wound healing in diabetes12
Drug repurposing strategies and key challenges for COVID-19 management12
Metformin combats obesity by targeting FTO in an m6A-YTHDF2-dependent manner12
Recent advancement on albumin nanoparticles in treating lung carcinoma12
Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubbles12
Molecular and cellular biology of PCSK9: impact on glucose homeostasis11
Biomimetic Ca2+ nanogenerator based on ions interference strategy for tumour-specific therapy11
Macrophage targeted triptolide micelles capable of cGAS-STING pathway inhibition for rheumatoid arthritis treatment11
Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy11
Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer10
New designed pH-responsive histidine-rich peptides with antitumor activity10
Lymphatic targeting for therapeutic application using nanoparticulate systems10
Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials10
Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes10
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis10
Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists10
Recent developments in nanoparticles for the treatment of diabetes10
Biomimetic graphene oxide quantum dots nanoparticles targeted photothermal-chemotherapy for gastric cancer10
Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer10
Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review9
Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform9
Legumain protease-sheddable PEGylated, tuftsin-modified nanoparticles for selective targeting to tumour-associated macrophages9
Advances in autophagy as a target in the treatment of tumours9
Smart delivery of epirubicin to cancer cells using aptamer-modified ferritin nanoparticles9
PVAT targets VSMCs to regulate vascular remodelling: angel or demon9
Tumour targeted polymer nanoparticles co-loaded with docetaxel and siCCAT2 for combination therapy of lung cancer9
Improving protection effects of eucalyptol via carboxymethyl chitosan-coated lipid nanoparticles on hyperglycaemia-induced vascular endothelial injury in rats9
Current approaches and future prospects of nanofibers: a special focus on antimicrobial drug delivery9
Metformin protects cardiomyocytes against oxygen-glucose deprivation injury by promoting autophagic flux through AMPK pathway9
Application of nanotechnology in management and treatment of diabetic wounds9
0.032299041748047